Effects of Chinese herbal medicines on intestinal drug absorption

Yakugaku Zasshi

Volumn 125, Issue 4, 2005, Pages 363-369

  Nishimura, Nobuhiro ^a  

^a SHIMANE UNIVERSITY HOSPITAL   (Japan)

Author keywords

Drug interaction; Intestinal absorption; MDR1; Sho saiko to; Tolbutamide

Indexed keywords

2,4 DINITROPHENOL; 4,4' DIISOTHIOCYANATOSTILBENE 2,2' DISULFONIC ACID; ACETIC ACID; BENZOIC ACID; CARBONYL CYANIDE 4 (TRIFLUOROMETHOXY)PHENYLHYDRAZONE; GLYCYLSARCOSINE; GLYCYRRHIZA EXTRACT; GLYCYRRHIZIC ACID; HERBACEOUS AGENT; LACTIC ACID; LIQUIRITIN; MULTIDRUG RESISTANCE PROTEIN 1; PROBENECID; SODIUM AZIDE; SUCCINIC ACID; SULFONYLUREA DERIVATIVE; TOLBUTAMIDE; XIAO CHAI HU TANG;

CELL STRAIN CACO 2; CHINESE MEDICINE; DRUG ABSORPTION; DRUG EFFECT; DRUG PENETRATION; DRUG POTENTIATION; DRUG TRANSPORT; GLYCYRRHIZA; HERBAL MEDICINE; HUMAN; HYPOGLYCEMIA; IN VIVO STUDY; INTESTINE ABSORPTION; INTESTINE EPITHELIUM; INTRACELLULAR TRANSPORT; JEJUNUM; MEMBRANE PERMEABILITY; NONHUMAN; PASSIVE TRANSPORT; PHARMACODYNAMICS; REVIEW;

ANIMALS; CACO-2 CELLS; CELL MEMBRANE PERMEABILITY; CELLS, CULTURED; DRUG INTERACTIONS; DRUG THERAPY, COMBINATION; DRUGS, CHINESE HERBAL; HUMANS; HYPOGLYCEMIC AGENTS; INTESTINAL ABSORPTION; JEJUNUM; P-GLYCOPROTEIN; RATS; SULFONYLUREA COMPOUNDS; TOLBUTAMIDE;

EID: 18244380082     PISSN: 00316903     EISSN: None     Source Type: Journal    
DOI: 10.1248/yakushi.125.363     Document Type: Review

References (27)

1. Ishizaki T., Sasaki F., Ameshima S., Shiozaki K., Takahashi H., Abe Y., Ito S., Kuriyama M., Nakai T., Kitagawa M., Eur. Respir. J., 9, 2691-2696 (1996).
2. Pharmaceutical and Food Safety Bureau: Pharmaceuticals and Medical Devices Safety Information No. 158, (2000).
3. Henderson L., Yue Q. Y., Bergquist C., Gerden B., Arlett P., Br. J. Clin. Pharmacol. 54, 349-356 (2002).
4. Miller L. G., Arch. Int. Med., 15g, 2200-2211 (1998).
5. Nishimura N., Naora K., Hirano H., Iwamoto K., Proc. 16th Asian Congress of Pharm. Sci., 1997, pp. 120-125.
6. Nishimura N., Naora K., Hirano H., Iwamoto K., J. Pharm. Pharmacol., 50, 231-236 (1998).
7. Nishimura N., Naora K., Hirano H., Iwamoto K., Am. J. Chin. Med., 21, 355-363 (1999).
8. Hansen J. M., Christensen L. K., Drugs, 13, 24-34 (1977).
9. Jackson J. E., Bressler R., Drugs, 22, 295-320 (1981).
10. Wahlin-Boll E., Melander A., Sartor G., Schersten B., Eur. J. Clin. Pharmacol., 18, 279-283 (1980).
11. Ikegami H., Shima K., Tanaka A., Tahara Y., Hirota M., Kumahara Y., Acta Endocrinol., 111, 528-532 (1986).
12. Yamaoka K., Nakagawa T., Uno T., J. Pharmacokin. Biopharm., 6, 547-551 (1978).
13. Sakai M., Imai T., Ohtake H., Azuma H., Otagiri M., J. Pharm. Pharmacol., 51, 27-33 (1999).
14. Sakai K., Oshima N., Kutsuna T., Miyazaki Y., Nakajima H., Muraoka T., Okuma K., Nishino T., Yakugaku Zasshi, 106, 947-950 (1986).
15. Nishimura N., Naora K., Hirano H., Iwamoto K., Biol. Pharm. Bull., 24, 409-413 (2001).
16. Nishimura N., Naora K., Hirano H., Iwamoto K., Yakugaku Zasshi, 121, 153-159 (2001).
17. Doluisio J., Billups N. F., Dittert L. W., Sugita E. T., Swintosky J., J. Pharm. Sci., 58, 1196-1200 (1969).
18. Yuasa H., Kuno C., Watanabe J., J. Pharm. Pharmacol., 49, 26-29 (1997).
19. Nishimura N., Naora K., Uemura T., Hirano H., Iwamoto K., Drug Metabol. Pharmacokin., 19, 48-54 (2004).
20. Tanaka Y., Taki Y., Sakane T., Nadai T., Sezaki H., Yamashita S., Pharm. Res., 12, 523-528 (1995).
21. Tsuji A., Tamai I., Pharm. Res., 13, 963-977 (1996).
22. Tamai I., Yakugaku Zasshi, 117, 415-434 (1997).
23. Tsuji A., Tamai I., Pharmaceut. Biotech., 12, 471-491 (1995).
24. Terao T., Hisanaga E., Sai Y., Tamai I., Tsuji A., J. Pharm. Pharmacol., 48, 1083-1089 (1996).
25. Nishimura N., Uemura T., Yamamoto A., Hirano H., Naora K., Iwamoto K., Abstract papers, the 63rd International Congress of International Pharmaceutical Federation, Sydney, September 2003, p. 26.
26. Uemura T., Nishimura N., Yamamoto A., Hirano H., Naora K., Iwamoto K., Abstract papers, the 2nd World Congress of the Board of Pharmaceutical Sciences of International Pharmaceutical Federation, Kyoto, May 2004, p. 161.
27. Schinkel A. H., Wagenaar E., van Deemter L., Mol C. A., Borst P., J. Clin. Invest., 96, 1698-1705 (1995).